Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes.

Stringer JS, Zulu I, Levy J, Stringer EM, Mwango A, Chi BH, Mtonga V, Reid S, Cantrell RA, Bulterys M, Saag MS, Marlink RG, Mwinga A, Ellerbrock TV, Sinkala M.

JAMA. 2006 Aug 16;296(7):782-93.

PMID:
16905784
2.

Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.

Sturt AS, Dokubo EK, Sint TT.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008440. doi: 10.1002/14651858.CD008440. Review.

PMID:
20238370
3.

Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults.

Siegfried N, Uthman OA, Rutherford GW.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008272. doi: 10.1002/14651858.CD008272.pub2. Review.

PMID:
20238364
4.

Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.

When To Start Consortium., Sterne JA, May M, Costagliola D, de Wolf F, Phillips AN, Harris R, Funk MJ, Geskus RB, Gill J, Dabis F, Miró JM, Justice AC, Ledergerber B, Fätkenheuer G, Hogg RS, Monforte AD, Saag M, Smith C, Staszewski S, Egger M, Cole SR.

Lancet. 2009 Apr 18;373(9672):1352-63. doi: 10.1016/S0140-6736(09)60612-7. Epub 2009 Apr 8. Review.

5.

Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis.

Suthar AB, Lawn SD, del Amo J, Getahun H, Dye C, Sculier D, Sterling TR, Chaisson RE, Williams BG, Harries AD, Granich RM.

PLoS Med. 2012;9(7):e1001270. doi: 10.1371/journal.pmed.1001270. Epub 2012 Jul 24. Review.

6.

Priorities for antiretroviral therapy research in sub-Saharan Africa: a 2002 consensus conference in Zambia.

Zulu I, Schuman P, Musonda R, Chomba E, Mwinga K, Sinkala M, Chisembele M, Mwaba P, Kasonde D, Vermund SH.

J Acquir Immune Defic Syndr. 2004 Jul 1;36(3):831-4. Review.

7.

Diagnostic accuracy of the WHO clinical staging system for defining eligibility for ART in sub-Saharan Africa: a systematic review and meta-analysis.

Munthali C, Taegtmeyer M, Garner PG, Lalloo DG, Squire SB, Corbett EL, Ford N, MacPherson P.

J Int AIDS Soc. 2014 Jun 12;17:18932. doi: 10.7448/IAS.17.1.18932. eCollection 2014. Review.

8.

Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review.

Rosen S, Fox MP.

PLoS Med. 2011 Jul;8(7):e1001056. doi: 10.1371/journal.pmed.1001056. Epub 2011 Jul 19. Review.

9.

Immunological profile in persons under antiretroviral therapy in a rural Nigerian hospital.

Musa BM, Gebi U, Etiebet MA, Omuh H, Ekedegwa P, Dakum P, Blattner W.

J Public Health Afr. 2010 Aug 19;1(1):e3. doi: 10.4081/jphia.2010.e3. eCollection 2010 Sep 1. Review.

10.

Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysis.

Gupta A, Nadkarni G, Yang WT, Chandrasekhar A, Gupte N, Bisson GP, Hosseinipour M, Gummadi N.

PLoS One. 2011;6(12):e28691. doi: 10.1371/journal.pone.0028691. Epub 2011 Dec 29. Review.

11.

Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis.

Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, Singh S, Rachlis B, Wu P, Cooper C, Thabane L, Wilson K, Guyatt GH, Bangsberg DR.

JAMA. 2006 Aug 9;296(6):679-90. Review.

PMID:
16896111
12.

Non-physician clinician provided HIV treatment results in equivalent outcomes as physician-provided care: a meta-analysis.

Emdin CA, Chong NJ, Millson PE.

J Int AIDS Soc. 2013 Jul 3;16:18445. doi: 10.7448/IAS.16.1.18445. Review.

13.

Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa.

Lawn SD, Harries AD, Anglaret X, Myer L, Wood R.

AIDS. 2008 Oct 1;22(15):1897-908. doi: 10.1097/QAD.0b013e32830007cd. Review.

14.

When to start antiretroviral therapy in adults in low- and middle-income countries: science and practice.

Munderi P.

Curr Opin HIV AIDS. 2010 Jan;5(1):6-11. doi: 10.1097/COH.0b013e32833384d3. Review.

PMID:
20046142
15.

Emerging technologies for point-of-care CD4 T-lymphocyte counting.

Boyle DS, Hawkins KR, Steele MS, Singhal M, Cheng X.

Trends Biotechnol. 2012 Jan;30(1):45-54. doi: 10.1016/j.tibtech.2011.06.015. Epub 2011 Jul 26. Review.

16.

Outcomes of HIV-positive patients lost to follow-up in African treatment programmes.

Zürcher K, Mooser A, Anderegg N, Tymejczyk O, Couvillon MJ, Nash D, Egger M; IeDEA and MESH consortia..

Trop Med Int Health. 2017 Apr;22(4):375-387. doi: 10.1111/tmi.12843. Epub 2017 Feb 20. Review.

17.

Impact of point-of-care CD4 testing on linkage to HIV care: a systematic review.

Wynberg E, Cooke G, Shroufi A, Reid SD, Ford N.

J Int AIDS Soc. 2014 Jan 20;17:18809. doi: 10.7448/IAS.17.1.18809. eCollection 2014. Review.

18.

From access to engagement: measuring retention in outpatient HIV clinical care.

Mugavero MJ, Davila JA, Nevin CR, Giordano TP.

AIDS Patient Care STDS. 2010 Oct;24(10):607-13. doi: 10.1089/apc.2010.0086. Review.

19.

Primary HIV infection: to treat or not to treat?

Fidler S, Fox J, Porter K, Weber J.

Curr Opin Infect Dis. 2008 Feb;21(1):4-10. doi: 10.1097/QCO.0b013e3282f428bf. Review.

PMID:
18192779

Supplemental Content

Support Center